| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927114 | American Heart Journal | 2011 | 12 Pages |
Abstract
Although the incidence of GIB associated with PCI decreased from 1998 to 2006 in the face of aggressive therapies for ACS and CAD, the risk of GIB-associated death remained high. Underlying GI malignancy is a significant independent predictor of GIB associated with PCI; identifying these patients may reduce the rate of GIB.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anupama MD, Vikas MD, Gregg C. MD, Hui PhD, Adhir R. MD, MPH, Mladen I. MD, FACC, FSCAI,